Cancer Hospital Chinese Academy of Medical Sciences,Shenzhen Center
Cancer Hospital Chinese Academy of Medical Sciences,Shenzhen Center
Shenzhen, China2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| To Evaluate KC1036 in the Patients with Advanced Digestive System Tumors | Digestive System Tumors | Recruiting | Phase 1 / Phase 2 | 2024-10-17 | NCT05260385 | |
| Efficacy and Safety of Almonertinib Combined With or Without Chemotherapy as an Adjuvant Treatment for Stage II-IIIA Non-small Cell Lung Carcinoma Following Complete Tumour Resection | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Enrolling by invitation | Phase 3 | 2022-02-24 | NCT04762459 |